Catalyst Pharmaceuticals, Inc. (CPRX)
Jul 15, 2026 - CPRX was delisted (reason: acquired by Angelini Pharma)
31.49
0.00 (0.00%)
Inactive · Last trade price on Jul 15, 2026
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 182 employees as of December 31, 2025. The number of employees increased by 1 or 0.55% compared to the previous year.
Employees
182
Change (1Y)
1
Growth (1Y)
0.55%
Revenue / Employee
$3,279,989
Profits / Employee
$1,216,060
Market Cap
3.85B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 182 | 1 | 0.55% |
| Dec 31, 2024 | 181 | 14 | 8.38% |
| Dec 31, 2023 | 167 | 85 | 103.66% |
| Dec 31, 2022 | 82 | 6 | 7.89% |
| Dec 31, 2021 | 76 | 2 | 2.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
CPRX News
- 1 day ago - Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst - Reuters
- 1 day ago - Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals - GlobeNewsWire
- 8 days ago - Solaris to replace Catalyst Pharmaceuticals in the S&P 600 at open on 7/15 - TheFly
- 9 days ago - Catalyst Pharmaceuticals Transcript: EGM 2026 - Transcripts
- 17 days ago - Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses - GlobeNewsWire
- 17 days ago - Catalyst Pharmaceuticals Proxy statement: Proxy filing - Filings
- 5 weeks ago - Catalyst Pharmaceuticals Proxy statement: Proxy filing - Filings
- 7 weeks ago - Catalyst Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TheFly